N-methacryloylhistidine | 67391-96-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-methacryloylhistidine
• 英文别名: 3-(1H-imidazol-5-yl)-2-(2-methylprop-2-enoylamino)propanoic acid
• CAS: 67391-96-2
• 化学式: C₁₀H₁₃N₃O₃
• 分子量: 223.232
• InChiKey: ADESRODTHOCWKB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  95.1
• 氢给体数：
  3
• 氢受体数：
  4

文献信息

• Cobalt imprinted polymer composition for selective removal of cobalt, process for preparation thereof, and process for removal of cobalt
  申请人：Kulkarni Gopalkrishna Mohan

  公开号：US20050070676A1

  公开（公告）日：2005-03-31

  The present invention provides a polymer composition for the selective removal of cobalt, a process for the preparation thereof and the process for removal of cobalt, using the said polymer composition. More particularly it relates to a cross-linked polymer composition prepared by the molecular imprinting technique. The preparation of the cross linked polymer involves selection of vinyl monomers bearing functional groups that bind to cobalt, formation of a complex of these monomers with cobalt and subsequent polymerization of the complex in presence of a crosslinker. The process for the removal of cobalt comprises treating the solution containing a mixture of cobalt and other metal ions with the polymer under conditions sufficient for cobalt to form a complex with the polymer and separating the polymer from the cobalt depleted solution.

  本发明提供了一种用于选择性除钴的聚合物组合物、其制备工艺以及使用上述聚合物组合物的除钴工艺。本发明尤其涉及一种通过分子印迹技术制备的交联聚合物组合物。交联聚合物的制备包括选择带有与钴结合的官能团的乙烯基单体，形成这些单体与钴的络合物，然后在交联剂存在下使络合物聚合。除钴工艺包括在足以使钴与聚合物形成络合物的条件下，用聚合物处理含有钴和其他金属离子混合物的溶液，并将聚合物从去钴溶液中分离出来。
• Composition containing a penem or carbapenem antibiotic
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0226304B1

  公开（公告）日：1991-08-28
• POLYMÈRE À EMPREINTE ET PROCÉDÉ DE PRÉPARATION
  申请人：Université de Toulon

  公开号：EP2935376B1

  公开（公告）日：2019-06-12
• BIOMIMETIC POLYMERS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES
  申请人：RensaVir, Inc.

  公开号：US20170253647A1

  公开（公告）日：2017-09-07

  Antiviral biomimetic polymers (ABPs) are disclosed that can be used to prevent and/or treat viral disease. The ABPs are discovered by a process involving high-throughput screening of polymer libraries using disease-relevant bioactive molecules as target molecules. ABPs can be nanoscale (termed nanoABPs) or larger. Methods are described for the preparation and use of ABPs as prophylactics and therapeutics (in vivo) and as preventative agents, for example, in personal protective equipment (ex vivo). ABPs can be used to prevent and treat viral diseases including those caused by Filoviridae.
• US4757066A
  申请人：——

  公开号：US4757066A

  公开（公告）日：1988-07-12